Apimeds Pharmaceuticals US, Inc.'s latest marketcap:
As of 07/29/2026, Apimeds Pharmaceuticals US, Inc.'s market capitalization has reached $21.3 M. According to our data, Apimeds Pharmaceuticals US, Inc. is the 37288th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 21.3 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 0 |
| Shares Out | 11.58 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/18/2026 |
Apimeds Pharmaceuticals US, Inc.'s yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/29/2026 | $21.3 M | 880.49% | 37288 |
| 12/31/2025 | $2.06 M | n/a |
Company Profile
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States.
It researches, develops, manufactures, commercializes, and sells Apitox, a purified, pharmaceutical grade venom of the Apis mellifera, or honeybee for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis.
The company was incorporated in 2020 and is based in Hopewell, New Jersey.
Frequently Asked Questions
-
What is Apimeds Pharmaceuticals US, Inc.'s (APUS) current market cap?As of 07/29/2026, Apimeds Pharmaceuticals US, Inc. (including the parent company, if applicable) has an estimated market capitalization of $21.3 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Apimeds Pharmaceuticals US, Inc. (APUS) rank globally by market cap?Apimeds Pharmaceuticals US, Inc. global market capitalization ranking is approximately 37288 as of 07/29/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.